Spineology Secures $25 Million in Equity Financing to Accelerate Growth and Innovation

Spineology, a leader in Conform and Expand™ spinal fusion technology, has successfully closed a $25 million Series AA funding round. The investment was led by SV Health Investors, with additional contributions from 1315 Capital and existing investor RC Capital. This new funding is set to drive Spineology’s expansion in commercial growth, clinical education, and product…

Read More

Noze Receives Historic $5M Investment from Bill & Melinda Gates Foundation to Advance Breath-Based Diagnostics

Noze, the innovative leader in breath-based diagnostic technology, has secured a transformative $5 million equity investment from the Bill & Melinda Gates Foundation. This groundbreaking funding is notable as it represents the Gates Foundation’s inaugural equity investment in a Canadian enterprise. The new investment, part of an extended funding round, builds on previous grants totaling…

Read More

Protembis Secures €20 Million from EIB to Advance Brain Protection Technology in Heart Treatments

The European Investment Bank (EIB) has announced a significant €20 million venture-debt financing deal with German medtech innovator Protembis. This funding is set to propel the development of Protembis’ cutting-edge ProtEmbo Cerebral Embolic Protection system, designed to safeguard patients’ brains during catheter-based heart procedures. Protembis, known for its trailblazing approach to medical technology, will utilize…

Read More

Thyme Care Secures $95M Series C Funding to Drive Accessibility and Affordability in Cancer Care

Thyme Care, a trailblazer in value-based cancer care solutions, has successfully closed a $95 million Series C funding round, marking a significant milestone in its mission to revolutionize cancer care accessibility and affordability. This financing, comprising $55 million in equity from new investor Concord Health Partners and existing supporters like CVS Health® Ventures, Town Hall…

Read More

Nurami Medical Secures €2.5 Million EIC Grant to Propel Innovations in Soft Tissue Repair

Nurami Medical, a trailblazer in the development of advanced solutions for soft tissue repair, announced today a significant milestone in its journey towards transforming the medical landscape. The company has been awarded a €2.5 million grant from the European Innovation Council (EIC) Horizon Accelerator program, coupled with additional equity investment. This funding underscores Nurami’s pioneering…

Read More

SamanTree Medical Secures $14M Series B to Propel Global Expansion and Surgical Innovation

SamanTree Medical, a trailblazer in medical technology focusing on enhancing surgical outcomes, has successfully closed a $14 million Series B funding round. The capital infusion, spearheaded by Relyens Innovation Santé and advised by Turenne Capital, marks a pivotal moment for the company as it accelerates its mission to advance the field of surgical imaging. The…

Read More

Eye Floater Breakthrough! PulseMedica Secures $12 Million CAD to Advance Imaging and Treatment Technology

Good news for anyone experiencing those pesky eye floaters! PulseMedica, a rising star in the life sciences field, has secured $12 million CAD in funding to revolutionize how we diagnose and treat these vision disruptions. This investment fuels the development of their innovative platform, offering a beacon of hope for millions who struggle with these…

Read More

Velentium Powers Up for Growth with $15 Million Injection from Trinity Capital

Velentium, a Houston-based engineering leader in medical device design and manufacturing, has secured a significant $15 million investment from Trinity Capital Inc. This strategic partnership fuels Velentium’s mission to deliver innovative and life-saving medical technologies. Velentium’s expertise spans across the entire medical device lifecycle, from concept to production. Their team offers a unique blend of…

Read More

Neuspera Medical Secures $23 Million to Advance Minimally Invasive Treatment for Overactive Bladder

Neuspera Medical, a company pioneering a discreet and minimally invasive treatment for overactive bladder (OAB), has secured $23 million in Series D financing. This significant investment round, led by Vertex Ventures HC and Treo Ventures, will propel Neuspera’s Neuspera System through U.S. Food and Drug Administration (FDA) premarket approval (PMA) and towards commercialization. OAB, a…

Read More

Spotlight Medical Secures €6.2 Million to Revolutionize Cancer Care with AI-Powered Prognosis Tests

A beacon of hope emerged in the fight against cancer this week, as Spotlight Medical, a pioneering French startup, announced securing €6.2 million in seed funding. This significant investment, led by renowned healthcare innovation firms Kurma Partners and Heal Capital, propels the company’s mission to transform cancer treatment through the power of artificial intelligence (AI)….

Read More